Literature DB >> 7966630

Effect of a single amino acid substitution in the V3 domain of the human immunodeficiency virus type 1: generation of revertant viruses to overcome defects in infectivity in specific cell types.

J F Morris1, E J Sternberg, L Gutshall, S R Petteway, L A Ivanoff.   

Abstract

Proviral clones of human immunodeficiency virus type 1 which contained single amino acid changes in the envelope V3 region were constructed. PCR amplification of Sup-T1 T cells transfected with one such mutant, G312T, revealed low levels of virus that resulted in the generation of a revertant virus, in which an alanine replaced the threonine residue at amino acid 312. The revertant virus (rA312) was fully infectious in Sup-T1 cells but lacked the ability to infect AA5 cells. The presence of a second mutation in a subsequent revertant virus (rR306), in which arginine was substituted for serine at amino acid 306 within the V3 loop, restored the ability of the mutated virus to infect AA5 cells. Our data highlight the importance of the V3 loop in defining virus tropism for specific cell types in culture and further suggest that a degree of interplay exists among V3 loop residues that helps maintain or control its biological function of the virus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7966630      PMCID: PMC237307          DOI: 10.1128/JVI.68.12.8380-8385.1994

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes.

Authors:  P Westervelt; H E Gendelman; L Ratner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

2.  Antibodies from human immunodeficiency virus-infected individuals bind to a short amino acid sequence that elicits neutralizing antibodies in animals.

Authors:  W R Kenealy; T J Matthews; M C Ganfield; A J Langlois; D M Waselefsky; S R Petteway
Journal:  AIDS Res Hum Retroviruses       Date:  1989-04       Impact factor: 2.205

3.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

4.  Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant.

Authors:  G J LaRosa; J P Davide; K Weinhold; J A Waterbury; A T Profy; J A Lewis; A J Langlois; G R Dreesman; R N Boswell; P Shadduck
Journal:  Science       Date:  1990-08-24       Impact factor: 47.728

5.  Host range mutant of human immunodeficiency virus type 1: modification of cell tropism by a single point mutation at the neutralization epitope in the env gene.

Authors:  Y Takeuchi; M Akutsu; K Murayama; N Shimizu; H Hoshino
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

6.  Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates.

Authors:  M Tersmette; R A Gruters; F de Wolf; R E de Goede; J M Lange; P T Schellekens; J Goudsmit; H G Huisman; F Miedema
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

7.  Functional interaction of constant and variable domains of human immunodeficiency virus type 1 gp120.

Authors:  R L Willey; E K Ross; A J Buckler-White; T S Theodore; M A Martin
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

8.  Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

Authors:  S S Hwang; T J Boyle; H K Lyerly; B R Cullen
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

9.  Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene.

Authors:  T Shioda; J A Levy; C Cheng-Mayer
Journal:  Nature       Date:  1991-01-10       Impact factor: 49.962

10.  Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.

Authors:  K Javaherian; A J Langlois; C McDanal; K L Ross; L I Eckler; C L Jellis; A T Profy; J R Rusche; D P Bolognesi; S D Putney
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

View more
  8 in total

1.  Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes.

Authors:  E G Cormier; D N Tran; L Yukhayeva; W C Olson; T Dragic
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Identification of amino acid substitutions associated with neutralization phenotype in the human immunodeficiency virus type-1 subtype C gp120.

Authors:  Jennifer L Kirchherr; Jennifer Hamilton; Xiaozhi Lu; S Gnanakaran; Mark Muldoon; Marcus Daniels; Webster Kasongo; Victor Chalwe; Chanda Mulenga; Lawrence Mwananyanda; Rosemary M Musonda; Xing Yuan; David C Montefiori; Bette T Korber; Barton F Haynes; Feng Gao
Journal:  Virology       Date:  2010-10-30       Impact factor: 3.616

3.  High frequency of mutations that expand the host range of an RNA virus.

Authors:  Martin T Ferris; Paul Joyce; Christina L Burch
Journal:  Genetics       Date:  2007-04-03       Impact factor: 4.562

4.  Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1.

Authors:  M Poss; H L Martin; J K Kreiss; L Granville; B Chohan; P Nyange; K Mandaliya; J Overbaugh
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

5.  Spontaneous reversion of human immunodeficiency virus type 1 neutralization-resistant variant HXB2thr582: in vitro selection against cytopathicity highlights gp120-gp41 interactive regions.

Authors:  T L Stern; M S Reitz; M Robert-Guroff
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

6.  Investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17gag and env genes.

Authors:  E S Hughes; J E Bell; P Simmonds
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

7.  High throughput functional analysis of HIV-1 env genes without cloning.

Authors:  Jennifer L Kirchherr; Xiaozhi Lu; Webster Kasongo; Victor Chalwe; Lawrence Mwananyanda; Rosemary M Musonda; Shi-Mao Xia; Richard M Scearce; Hua-Xin Liao; David C Montefiori; Barton F Haynes; Feng Gao
Journal:  J Virol Methods       Date:  2007-04-09       Impact factor: 2.014

8.  Role of HIV-1 subtype C envelope V3 to V5 regions in viral entry, coreceptor utilization and replication efficiency in primary T-lymphocytes and monocyte-derived macrophages.

Authors:  Vasudha Sundaravaradan; Suman R Das; Rajesh Ramakrishnan; Shobha Sehgal; Sarla Gopalan; Nafees Ahmad; Shahid Jameel
Journal:  Virol J       Date:  2007-11-24       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.